GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » 6-1 Month Momentum %

BrightPath Biotherapeutics Co (TSE:4594) 6-1 Month Momentum % : -42.98% (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-28), BrightPath Biotherapeutics Co's 6-1 Month Momentum % is -42.98%.

The industry rank for BrightPath Biotherapeutics Co's 6-1 Month Momentum % or its related term are showing as below:

TSE:4594's 6-1 Month Momentum % is ranked worse than
86.07% of 1522 companies
in the Biotechnology industry
Industry Median: 4.02 vs TSE:4594: -42.98

Competitive Comparison of BrightPath Biotherapeutics Co's 6-1 Month Momentum %

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrightPath Biotherapeutics Co's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's 6-1 Month Momentum % falls into.



BrightPath Biotherapeutics Co  (TSE:4594) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BrightPath Biotherapeutics Co  (TSE:4594) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


BrightPath Biotherapeutics Co 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


BrightPath Biotherapeutics Co (TSE:4594) Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines